대출 자본 변화 날짜
Acadia Pharmaceuticals USD 0 0 2025-03
Akebia Therapeutics USD 12.78M 11.98M 2026-09
ALKERMES USD 1.47B 5.38M 2026-09
Alnylam Pharmaceuticals USD 2.11B 358.58M 2026-09
ANI Pharmaceuticals USD 274.31M 5.84M 2026-09
BioMarin Pharmaceutical USD 3.51B 12.96M 2026-09
Coherus Biosciences USD 51.08M 496K 2025-12
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Glaxosmithkline GBP 28.79B 10.26B 2026-09
Heron Therapeutics USD 140.64M 975K 2025-12
Ionis Pharmaceuticals USD 1.77B 140.62M 2026-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Lexicon Pharmaceuticals USD 49.68M 276K 2026-03
Lonza CHF 3.88B 323M 2025-12
Merck USD 49.69B 1.39B 2026-09
Moderna USD 3.55B 2.95B 2026-09
Myriad Genetics USD 120.7M 400K 2026-06
Nektar Therapeutics USD 60.27M 2.89M 2026-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pacira USD 11.59B 11.22B 2026-09
Pfizer USD 60B 498M 2026-09
PTC Therapeutics USD 536.27M 749K 2026-09
Sanofi EUR 16.28B 1.63B 2026-09
Sarepta Therapeutics USD 699.39M 148.23M 2026-09
United Therapeutics USD 100M 100M 2024-06
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12